A randomized, double blind, placebo-controlled trial of zinc and astaxanthin among mild glucose intolerance

A randomized, double blind, placebo-controlled trial of zinc and astaxanthin among mild glucose intolerance - A randomized, double blind, placebo-controlled trial of zinc and astaxanthin among mild glucose intolerance

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017118

Enrollment

120

Registered

2015-04-13

Start date

2015-02-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mild glucose intolerance

Interventions

placebo zinc zinc and astaxanthin zinc and astaxanthin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Level of GA: 15.6%-18.3%

Exclusion criteria

Exclusion criteria: diabetic disease current use of substances or medications known to affect sleep, including prescription psychotropics, sedatives, hypnotics

Design outcomes

Primary

Measure	Time frame
HbA1c,GA	—

Secondary

Measure	Time frame
AIS,PSQI,CESD,SF8,sleep log Actigraph T-C,HDL-C,LDL-C,TG BUN,s-cre,e-GFR Zn Blood pressure BMI	—

Countries

Japan

Contacts

Public ContactYoko Komada

Tokyo Medical University Department of Somnology

ykoma@tokyo-med.ac.jp03-3351-6141

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026